Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Randomised, double-masked, sham-controlled, cross-over clinical trial of intravitreal faricimab for chronic central serous chorioretinopathy: study protocol.

Created on 13 Nov 2026

Authors

Noa Gilead, Ali Forouhari, Sobha Sivaprasad, Philippe Margaron, Kelvin Yi Chong Teo, Chui Ming Gemmy Cheung

Published in

BMJ open ophthalmology. Volume 11. Issue 4. Nov 12, 2026. Epub Nov 12, 2026.

PMID:
43020526
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement